Choh Yeung

3.3k total citations · 1 hit paper
23 papers, 2.3k citations indexed

About

Choh Yeung is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Choh Yeung has authored 23 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 12 papers in Pulmonary and Respiratory Medicine and 7 papers in Oncology. Recurrent topics in Choh Yeung's work include Sarcoma Diagnosis and Treatment (10 papers), Protein Degradation and Inhibitors (3 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers). Choh Yeung is often cited by papers focused on Sarcoma Diagnosis and Treatment (10 papers), Protein Degradation and Inhibitors (3 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers). Choh Yeung collaborates with scholars based in United States, Italy and Canada. Choh Yeung's co-authors include Lee J. Helman, Chand Khanna, Arnulfo Mendoza, Xiaolin Wan, Daniel Rotrosen, Harry L. Malech, Thomas L. Leto, Cheung H. Kwong, Stephen M. Hewitt and Javed Khan and has published in prestigious journals such as Science, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Choh Yeung

22 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis

2004 572 citations Chand Khanna, Xiaolin Wan et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Choh Yeung United States	16	1.1k	656	654	509	290	23	2.3k
Verena Tischler Switzerland	18	1.5k 1.3×	449 0.7×	1.1k 1.7×	367 0.7×	578 2.0×	46	2.7k
Noona Ambartsumian Denmark	30	2.2k 2.0×	670 1.0×	512 0.8×	763 1.5×	975 3.4×	42	3.2k
Orit Sagi‐Assif Israel	28	961 0.8×	302 0.5×	1.1k 1.6×	732 1.4×	445 1.5×	61	2.1k
Marina Kriajevska United Kingdom	25	1.9k 1.6×	297 0.5×	563 0.9×	458 0.9×	813 2.8×	37	2.3k
François Lamoureux France	31	1.6k 1.4×	717 1.1×	830 1.3×	216 0.4×	567 2.0×	73	2.5k
Tsipi Meshel Israel	28	939 0.8×	340 0.5×	1.5k 2.4×	1.1k 2.3×	470 1.6×	63	2.6k
Bruce E. Elliott Canada	26	1.1k 1.0×	119 0.2×	584 0.9×	272 0.5×	295 1.0×	62	1.9k
Koh‐ichi Nakashiro Japan	34	1.7k 1.5×	494 0.8×	1.4k 2.2×	492 1.0×	802 2.8×	127	3.3k
Jamila Laoukili Netherlands	20	1.7k 1.5×	316 0.5×	548 0.8×	293 0.6×	315 1.1×	30	2.5k
Luisa M. Solis United States	28	1.8k 1.5×	594 0.9×	831 1.3×	306 0.6×	662 2.3×	68	2.9k

Countries citing papers authored by Choh Yeung

Since Specialization

Citations

This map shows the geographic impact of Choh Yeung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Choh Yeung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Choh Yeung more than expected).

Fields of papers citing papers by Choh Yeung

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Choh Yeung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Choh Yeung. The network helps show where Choh Yeung may publish in the future.

Co-authorship network of co-authors of Choh Yeung

This figure shows the co-authorship network connecting the top 25 collaborators of Choh Yeung. A scholar is included among the top collaborators of Choh Yeung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Choh Yeung. Choh Yeung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ludwig, Katelyn R., Choh Yeung, Arnulfo Mendoza, et al.. (2024). Enhancing Standard of Care Chemotherapy Efficacy Using DNA-Dependent Protein Kinase (DNA-PK) Inhibition in Preclinical Models of Ewing Sarcoma. Molecular Cancer Therapeutics. 23(8). 1109–1123. 2 indexed citations

Yeung, Choh, et al.. (2020). Targeting Hippo-Dependent and Hippo-Independent YAP1 Signaling for the Treatment of Childhood Rhabdomyosarcoma. Cancer Research. 80(14). 3046–3056. 22 indexed citations

Yeung, Choh, Sameer H. Issaq, Yiping Zhang, et al.. (2020). Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) with OT-82 induces DNA damage, cell death, and suppression of tumor growth in preclinical models of Ewing sarcoma. Oncogenesis. 9(9). 80–80. 22 indexed citations

Heske, Christine M., Choh Yeung, Arnulfo Mendoza, et al.. (2016). The Role of PDGFR-β Activation in Acquired Resistance to IGF-1R Blockade in Preclinical Models of Rhabdomyosarcoma. Translational Oncology. 9(6). 540–547. 10 indexed citations

Wan, Xiaolin, Choh Yeung, Christine M. Heske, Arnulfo Mendoza, & Lee J. Helman. (2015). IGF-1R Inhibition Activates a YES/SFK Bypass Resistance Pathway: Rational Basis for Co-Targeting IGF-1R and Yes/SFK Kinase in Rhabdomyosarcoma. Neoplasia. 17(4). 358–366. 40 indexed citations

Grohar, Patrick J., Choh Yeung, Yves Pommier, et al.. (2013). Dual Targeting of EWS-FLI1 Activity and the Associated DNA Damage Response with Trabectedin and SN38 Synergistically Inhibits Ewing Sarcoma Cell Growth. Clinical Cancer Research. 20(5). 1190–1203. 60 indexed citations

Yeung, Choh, Vu N. Ngo, Patrick J. Grohar, et al.. (2013). Loss-of-function screen in rhabdomyosarcoma identifies CRKL-YES as a critical signal for tumor growth. Oncogene. 32(47). 5429–5438. 36 indexed citations

Wan, Xiaolin, Choh Yeung, Su Young Kim, et al.. (2012). Identification of FoxM1/Bub1b Signaling Pathway as a Required Component for Growth and Survival of Rhabdomyosarcoma. Cancer Research. 72(22). 5889–5899. 42 indexed citations

Grohar, Patrick J., Laurie B. Griffin, Choh Yeung, et al.. (2011). Ecteinascidin 743 Interferes with the Activity of EWS-FLI1 in Ewing Sarcoma Cells. Neoplasia. 13(2). 145–IN10. 97 indexed citations

10.

Grohar, Patrick J., Girma M. Woldemichael, Laurie B. Griffin, et al.. (2011). Identification of an Inhibitor of the EWS-FLI1 Oncogenic Transcription Factor by High-Throughput Screening. JNCI Journal of the National Cancer Institute. 103(12). 962–978. 164 indexed citations

11.

Petricoin, Emanuel F., Virginia Espina, Robyn P. Araujo, et al.. (2007). Phosphoprotein Pathway Mapping: Akt/Mammalian Target of Rapamycin Activation Is Negatively Associated with Childhood Rhabdomyosarcoma Survival. Cancer Research. 67(7). 3431–3440. 196 indexed citations

12.

Yeung, Choh, et al.. (2007). Evaluation of combined insulin-like growth factor type 1 (IGF1R) and mTOR pathway blockade in sarcoma xenograft models. Cancer Research. 67. 4760–4760. 1 indexed citations

13.

Kim, Su Young, Brieanne Midura, Choh Yeung, et al.. (2007). Inhibition of the CXCR4/CXCL12 chemokine pathway reduces the development of murine pulmonary metastases. Clinical & Experimental Metastasis. 25(3). 201–211. 202 indexed citations

14.

Yeung, Choh, Virginia Espina, Gabriel S. Eichler, et al.. (2005). Proteomic profiling identifies prognostic subsets in Rhabdomyosarcoma (RMS). Journal of Clinical Oncology. 23(16_suppl). 9502–9502.

15.

Khanna, Chand, Xiaolin Wan, Ryan D. Cassaday, et al.. (2004). The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis. Nature Medicine. 10(2). 182–186. 572 indexed citations breakdown →

16.

Khanna, Chand, Javed Khan, Choh Yeung, et al.. (2001). Metastasis-associated differences in gene expression in a murine model of osteosarcoma.. PubMed. 61(9). 3750–9. 229 indexed citations

17.

Navid, Fariba, John J. Letterio, Choh Yeung, D. Michiel Pegtel, & Lee J. Helman. (2000). Autocrine Transforming Growth Factor‐β Growth Pathway in MurineOsteosarcoma Cell Lines Associated with Inability to AffectPhosphorylation of Retinoblastoma Protein. Sarcoma. 4(3). 93–102. 10 indexed citations

18.

Khanna, C., et al.. (2000). An orthotopic model of murine osteosarcoma with clonally related variants differing in pulmonary metastatic potential. Clinical & Experimental Metastasis. 18(3). 261–271. 154 indexed citations

19.

Zhang, Lijuan, Min Kim, Yung Hyun Choi, et al.. (1999). Diminished G1 Checkpoint after γ-Irradiation and Altered Cell Cycle Regulation by Insulin-like Growth Factor II Overexpression. Journal of Biological Chemistry. 274(19). 13118–13126. 22 indexed citations

20.

Rotrosen, Daniel, Choh Yeung, & Julie P. Katkin. (1993). Production of recombinant cytochrome b558 allows reconstitution of the phagocyte NADPH oxidase solely from recombinant proteins. Journal of Biological Chemistry. 268(19). 14256–14260. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact